Joint statement from BIA/ABPI on EU Council meeting
“We are now fewer than nine months away from the day the UK leaves the EU and as it stands we still do not have a deal on the future relationship or any certainty on the conditions our companies are expected to operate under come 29 March 2019.
“Every month, 45 million packs of medicines move from the UK to the EU and 37 million come back the other way. Every month, the health of millions of EU and UK patients are dependent on our industry’s ability to move medicines and vaccines across borders without delays or interruption.”
Media enquiries: Ed Sexton: firstname.lastname@example.org 0207 6302196
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.